ENLIE Pharmaceutical JSC (HSTC:BCP) Institutional Ownership: 0.00% (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:BCP ENLIE Pharmaceutical JSC HSTC:BCP
25 GF Score
Price ₫10,600.00
View Full Analysis

What is ENLIE Pharmaceutical JSC Institutional Ownership?

ENLIE Pharmaceutical JSC HSTC:BCP 25 Institutional Ownership is 0.00% as of Jul. 14, 2026. GuruFocus rates HSTC:BCP with a GF Score™ of 25/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ENLIE Pharmaceutical JSC's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ENLIE Pharmaceutical JSC's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ENLIE Pharmaceutical JSC's Float Percentage Of Total Shares Outstanding is N/A.

ENLIE Pharmaceutical JSC Institutional Ownership Historical Data

* Premium members only.

The historical data trend for ENLIE Pharmaceutical JSC's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENLIE Pharmaceutical JSC Institutional Ownership Chart

ENLIE Pharmaceutical JSC Annual Data
Trend
Institutional Ownership

ENLIE Pharmaceutical JSC Semi-Annual Data
Institutional Ownership
HSTC:BCP
25GF Score
ENLIE Pharmaceutical JSC HSTC:BCP
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENLIE Pharmaceutical JSC Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.00% mean?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a Institutional Ownership of 0.00% as of Jul. 14, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on ENLIE Pharmaceutical JSC and its competitors.
Is ENLIE Pharmaceutical JSC's Institutional Ownership too high?
ENLIE Pharmaceutical JSC's current Institutional Ownership is 0.00%. Overall, ENLIE Pharmaceutical JSC has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENLIE Pharmaceutical JSC's Institutional Ownership compare to ?
ENLIE Pharmaceutical JSC's Institutional Ownership of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on ENLIE Pharmaceutical JSC and its competitors. ENLIE Pharmaceutical JSC's current Institutional Ownership is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENLIE Pharmaceutical JSC stock overvalued right now?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a current Institutional Ownership of 0.00%. The current Institutional Ownership is 0.00%. ENLIE Pharmaceutical JSC's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For ENLIE Pharmaceutical JSC (HSTC:BCP), the current Institutional Ownership is 0.00% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENLIE Pharmaceutical JSC Business Description

Comparable Companies
Address NA6 Street, My Phuoc 2 Industrial Park, Ben Cat district, Binh Duong, VNM
ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.
25GF Score

Get the complete analysis for HSTC:BCP

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫10,600.00
Price